# Ataraxis Real-World Clinical Outcomes Registry Linking AI-Based Pathology Scores to Patient Outcomes

> **NCT07706842** · — · NOT_YET_RECRUITING · sponsor: **Ataraxis AI, Inc.** · enrollment: 1000 (estimated)

## Conditions studied

- Solid Tumor Malignancy
- Breast Cancer

## Interventions

- **DIAGNOSTIC_TEST:** Ataraxis testing

## Key facts

- **NCT ID:** NCT07706842
- **Lead sponsor:** Ataraxis AI, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-10-31
- **Primary completion:** 2038-10
- **Final completion:** 2038-12
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2026-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07706842

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07706842, "Ataraxis Real-World Clinical Outcomes Registry Linking AI-Based Pathology Scores to Patient Outcomes". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07706842. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*